The CerviLenz device is used to measure vaginal cervical length during any prenatal visit.

The measurements aids obstetricians to verify and manage pregnant women at high risk for premature birth.

Cervilenz president and CEO Dean Koch said current progesterone technology alone will not be able to meet the need, and their new device is the perfect solution.

"We are confident that CerviLenz will play a vital role in reducing the rate of prematurity," Koch said.